rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Amy Moss Trombly

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Sonoma Pharmaceuticals; Director and 10% owner, Planetlink Communications.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
1
First trade
29 Aug 2007
Last trade
9 Jul 2026
Last filed
9 Jul 2026

Companies traded

Where they are an officer
SNOA Sonoma PharmaceuticalsOfficer · Medical Devices · last 9 Jul 20260 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Planetlink CommunicationsDirector, 10% owner · last 29 Aug 20070 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
9 Jul 2026filed 9 Jul 2026SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—10,000 at $0.00filing
9 Jul 2026filed 9 Jul 2026SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—10,000 at $0.00filing
2 Jan 2026filed 2 Jan 2026SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—10,000 at $0.00filing
2 Jan 2026filed 2 Jan 2026SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—10,000 at $0.00filing
19 Jun 2025filed 20 Jun 2025SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—13,500 at $0.00filing
2 Jan 2025filed 3 Jan 2025SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—10,000 at $0.00filing
20 Jun 2024filed 21 Jun 2024SNOA Sonoma PharmaceuticalsMedical DevicesSEC FORM 4 Code A—53,586filing
29 Dec 2023filed 29 Dec 2023SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—60,000filing
30 Jun 2023filed 3 Jul 2023SNOA Sonoma PharmaceuticalsMedical DevicesSEC FORM 4 Code A—100,000filing
29 Dec 2022filed 30 Dec 2022SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—40,000filing
14 Jan 2022filed 14 Jan 2022SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—30,000filing
7 Jan 2021filed 8 Jan 2021SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—27,777filing
2 Jan 2020filed 3 Jan 2020SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—2,380filing
31 Dec 2019filed 3 Jan 2020SNOA Sonoma Pharmaceuticalsoption or derivative · Medical DevicesSEC FORM 4 Code A—13,491filing
29 Aug 2007filed 17 Sep 2007Planetlink CommunicationsSEC FORM 4 Code A—1,375,000,000filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John McLaughlinDirector · Director at Sonoma Pharmaceuticals, filing Form 4 there in the last year
Jerome J. DvonchChief Financial Officer · Chief Financial Officer at Sonoma Pharmaceuticals, filing Form 4 there in the last year
Philippe WeigerstorferDirector · Director at Sonoma Pharmaceuticals, filing Form 4 there in the last year
Poggetto John DalController · Controller at Sonoma Pharmaceuticals, filing Form 4 there in the last year
Vanessa JacobyDirector · Director at Sonoma Pharmaceuticals, filing Form 4 there in the last year